Trials / Completed
CompletedNCT05001152
Taste Assessment of Ozanimod
An Open-Label Taste Assessment of Ozanimod in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the taste characteristics of ozanimod formulations, alone and mixed, in order to develop a pediatric oral form of ozanimod.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ozanimod | Taste assessment |
Timeline
- Start date
- 2021-09-09
- Primary completion
- 2021-09-17
- Completion
- 2021-09-27
- First posted
- 2021-08-11
- Last updated
- 2023-06-18
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05001152. Inclusion in this directory is not an endorsement.